Updates

We regularly publish updates on our company and news and trends in our industry.

Watch our latest videos for up to date information on our progress.

Featured news

Top news, resources and events

Stay informed with our most important news releases and media coverage, industry insights and presentations.

Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in Fibromyalgia

November 02, 2021

Scientific American: Can Psychedelic Drugs Treat Physical Pain?

September 30, 2021

GQ: How Albert Lin Treated His Phantom Limb Pain With Psychedelics

June 10, 2021

The Dales Report: Ladenburg Thalmann Initiates Research Coverage On Tryp Therapeutic

August 26, 2021

All news

See below for a comprehensive list of news items published by Tryp Therapeutics.

Filter by

Press releases

Industry news

Media

Tryp Therapeutics Appoints Robin Carhart-Harris, Ph.D. as SAB Chairman and Adds Daniel Clauw, M.D. as Scientific Advisor

July 26, 2021

Tryp Therapeutics Announces Plans for Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan

July 21, 2021

Tryp Therapeutics to Host Q3 Investor Day on July 29, 2021

July 15, 2021

Tryp Therapeutics Partners with the University of Michigan to Evaluate Proprietary Formulations

July 08, 2021

GQ: How Albert Lin Treated His Phantom Limb Pain With Psychedelics

June 10, 2021

Tryp Therapeutics to Present at the H.C. Wainwright Psychedelics Conference

June 01, 2021

Tryp Therapeutics Partners with Alcami for Proprietary Formulations

May 25, 2021

Tryp Therapeutics Partners with Clinlogix for Clinical Trial Support

May 10, 2021

Tryp Therapeutics Partners with Fluence for Psychotherapy Design

May 03, 2021

Tryp Therapeutics Announces Q2 2021 Financial Results

April 29, 2021